Xcout IntelSign inSubscribe

GSK PLC LS-,3125 competitors & alternatives

GS71PharmaceuticalsGermany

The 12 closest competitors and alternatives to GSK PLC LS-,3125 among pharmaceuticals companies — ranked by similarity to what GSK PLC LS-,3125 actually does, not by market-cap band.

12Competitors listed

Subscribe to see GSK PLC LS-,3125’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About GSK PLC LS-,3125

GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally. Its research and development efforts focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

GSK PLC LS-,3125 at a glance

GSK PLC LS-,3125 is a pharmaceuticals company headquartered in Germany. Xcout tracks 26 named people at GSK PLC LS-,3125, including Deborah Waterhouse (CEO, ViiV Healthcare and President, Global Health, GSK).

GSK PLC LS-,3125 leadership

  • Deborah WaterhouseCEO, ViiV Healthcare and President, Global Health, GSK
  • Luke MielsChief Executive Officer
  • Julie BrownChief Financial Officer
  • Mondher MahjoubiChief Patient Officer
  • Roanne ParryChief People Officer
  • Shobie RamakrishnanChief Digital and Technology Officer

20 more named people on record for GSK PLC LS-,3125, with roles, board committees and tenure — see the full roster →

Top 12 GSK PLC LS-,3125 competitors

Ranked by semantic similarity — how close each company is to GSK PLC LS-,3125 by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

AstraZenecaAZN · PharmaceuticalsCambridge, United Kingdom
68% matchPublicAI 12/100

Similar pharmaceuticals company

AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with primary and specialty care physicians worldwide, facilitating distribution through a robust network of representatives and local offices across the United Kingdom, continental Europe, the Americas, Asia, Africa, and Australasia. The firm actively drives innovation through strategic collaborations, partnering with entities such as Neurimmune AG for the development and commercialization of NI006, BenevolentAI for systemic lupus erythematosus drug discovery, Lunit for AI-powered digital pathology risk assessment in NSCLC, and Absci Corporation for AI-driven oncology target identification. Founded in 1992, the company was initially known as Zeneca Group PLC, subsequently rebranding to AstraZeneca PLC in April 1999, and maintains its headquarters in Cambridge, United Kingdom.

Market cap$246.9B
Employees96,100
Spark
AstraZeneca competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of GSK PLC LS-,3125 and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for GSK PLC LS-,3125and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →